September 17, 2021
To begin with, the headline of this article is problematic. Who says 20 times more antibodies, or 1,000 times more antibodies, means 20 times more protection. When we are told that Israel's 3rd booster is working marvels one wonders by what measure, since it is SO NEW.
It could be that people are heading for a screwed up immune system that does not know what is going on anymore. That is, it could be that God's natural immune system is being undermined by these vaccines. Anyone notice how ultra-vaccinated Israel has been doing against Covid lately? Hardly any country in the world is doing worse, and now we are supposed to trust that the 3rd booster will do the trick. That takes time to see short term, and a lot of time to see longterm. Are there going to be severely negative effects coming from these vaccines later on? They are all experimental you know, and NONE of them are "approved" by the FDA, not even the Pfizer vaccine...even though some people who do not know what they are talking about say that the Pfizer vaccine IS approved.
Further, there are anti-bodies and there are antibodies. God's natural immune system is designed to recognize a virus from many views and degrees, and is more capable of warding off a mutation than is a vaccination. Ever notice that the flu vaccines have to change every year because the flu is always changing, and most of the time the makers of the flu vaccine seem to guess wrong about what flu is coming? What we are told and what is true are often world's apart.
https://www.timesofisrael.com/study-covid-booster-recipients-20-times-more-protected-against-serious-illness/
Study: COVID booster recipients 20 times more protected against serious illness
As US officials set to mull okaying Pfizer’s 3rd dose, data from a million Israelis shows it boosts protection from infection tenfold compared with eligible people who got 2 shots
A new study conducted in Israel shows that individuals given a third COVID-19 vaccine dose are nearly twenty times more protected against serious illness and more than ten times more protected against infection, compared with those who received their second dose at least five months previously.
The research, published on Wednesday by The New England Journal of Medicine, showed that 12 days after receiving a booster shot of a Pfizer-BioNTech COVID-19 vaccine, the chance of infection was 11.3 times less than among those eligible for a third shot but didn’t get one.
And the chance of suffering serious illness as a result of COVID-19 among those who had received a booster shot was 19.5 times less, the research said.
The study was conducted by researchers from the Weizmann Institute of Science, the Ministry of Health, the Technion, the Hebrew University, Sheba Medical Center, and the KI Institute.
Even with a more conservative analysis, which attempted to control possible behavioral differences between the two groups, the infection rate was at least 5 times lower in the group that had received the booster shot, the Health Ministry said in a statement.
The research includes data from more than 1 million Israelis. Among those who hadn’t received a booster shot despite being eligible, there were 4,439 confirmed infections, including 294 serious patients. Among those who received the booster at least 12 days previously, there were 934 infections including 29 serious cases.
The Israeli data could not say how long the boosted protection lasts.
But a separate study conducted at Sheba Medical Center in Ramat Gan, outside Tel Aviv, has stoked optimism as to the amount of time for which the booster shot retains its protection.
The study found that the antibody levels a week after the third COVID-19 vaccine dose was administered to its staff were ten times higher than their levels a week after the second dose was administered.
Israel — the first country to officially offer a third dose — began its COVID-19 booster campaign on August 1, initially rolling it out to those over the age of 60. It then gradually dropped the eligibility age, eventually expanding it to everyone aged 12 and up who received the second shot at least five months ago.
As of Thursday, nearly 3 million Israelis had received their third dose.
Meanwhile in the US, influential government advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective — the first step toward deciding which Americans need one and when.